New hope for dialysis patients: drug AP301 targets dangerous phosphorus levels
Disease control
Completed
This study tested a new drug called AP301 in 474 adults with end-stage kidney disease on dialysis who have high phosphorus levels. The goal was to see if AP301 can safely lower phosphorus better than the current standard treatment, sevelamer carbonate. Participants received eithe…
Phase: PHASE3 • Sponsor: Alebund Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 10:10 UTC